Literature DB >> 30080779

The use of ABC score in activation of massive transfusion: The yin and the yang.

Amirreza T Motameni1, Rebekah A Hodge, William I McKinley, Jiliene M Georgel, Brian P Strollo, Matthew V Benns, Keith R Miller, Brian G Harbrecht.   

Abstract

BACKGROUND: Hemorrhage is the most common cause of early death in trauma patients. Massive transfusion protocols (MTPs) have been designed to accelerate the release of blood products but can result in waste if activated inappropriately. The Assessment of Blood Consumption (ABC) score has become a widely accepted score for MTP activation. In this study, we compared the use of ABC criteria to physician judgment in MTP activation.
METHODS: Adult trauma patients treated at University of Louisville Trauma Center from January 2016 to December 2016 were studied. Activation via ABC score was assessed retrospectively from emergency department (ED) data. Location, timing of activation, percent of patients using more than 5 units of packed red blood cells, amount of product waste, factors associated with early activation by physicians, and mortality were analyzed.
RESULTS: Three thousand four hundred twenty-one patients were included in this study. Only 33% of the patients who would have had MTP activation based on the ABC criteria used more than 5 units of blood products within 24 hours of admission compared with 65% of the patients in whom clinical judgment was used. Seventy-six percent of all MTP activations from clinical judgment would have been activated by the ABC criteria in the ED. Fifty-five percent of all MTP activations via clinical judgment were activated in the operating room and 41% in the ED. Eighty-one percent of activations that occurred in the operating room by physician judgment could have been activated earlier in the ED if the ABC criteria had been used. However, ABC score can lead to higher potential fresh frozen plasma waste (588 vs. 84 units) compared with physician judgment.
CONCLUSIONS: The ABC criteria overestimate need for massive transfusion and can lead to increased product waste compared with physician judgment, but its use leads to earlier MTP activation. Criteria to trigger MT activation should rely on both clinical acumen and validated prediction tools. LEVEL OF EVIDENCE: Prognostic, level III.

Entities:  

Mesh:

Year:  2018        PMID: 30080779     DOI: 10.1097/TA.0000000000001949

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  5 in total

1.  Multicenter Validation of the Revised Assessment of Bleeding and Transfusion (RABT) Score for Predicting Massive Transfusion.

Authors:  Kamil Hanna; Charles Harris; Marc D Trust; Andrew Bernard; Carlos Brown; Mohammad Hamidi; Bellal Joseph
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

2.  Thrombin Generation Kinetics are Predictive of Rapid Transfusion in Trauma Patients Meeting Critical Administration Threshold.

Authors:  Taleen A MacArthur; Grant M Spears; Rosemary A Kozar; Jing-Fei Dong; Matthew Auton; Donald H Jenkins; Kent R Bailey; Aneel A Ashrani; Mike J Ferrara; Joseph M Immermann; Timothy M Halling; Myung S Park
Journal:  Shock       Date:  2021-03-01       Impact factor: 3.533

3.  Shock index increase from the field to the emergency room is associated with higher odds of massive transfusion in trauma patients with stable blood pressure: A cross-sectional analysis.

Authors:  Shao-Chun Wu; Cheng-Shyuan Rau; Spencer C H Kuo; Shiun-Yuan Hsu; Hsiao-Yun Hsieh; Ching-Hua Hsieh
Journal:  PLoS One       Date:  2019-04-25       Impact factor: 3.240

4.  Shock index in patients with traumatic solid organ injury as a predictor of massive blood transfusion protocol activation.

Authors:  Ayman El-Menyar; Gaby Jabbour; Mohammad Asim; Husham Abdelrahman; Ismail Mahmood; Hassan Al-Thani
Journal:  Inj Epidemiol       Date:  2019-10-07

5.  A Cohort Study in Intensive Care Units: Health Decisions Related to Blood Transfusion during the COVID-19 Pandemic.

Authors:  Raúl Juárez-Vela; José Antonio García-Erce; Vicente Gea-Caballero; Regina Ruiz de Viñaspre-Hernandez; José Ángel Santos-Sánchez; Juan Luis Sánchez-González; Eva María Andrés-Esteban; Michał Czapla; Clara Isabel Tejada; Kapil Laxman Nanwani-Nanwani; Ainhoa Serrano-Lázaro; Manuel Quintana-Díaz
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.